Cargando…

Comparison of Clinical Characteristics and Outcomes Between Community-Acquired and Healthcare-Associated Bacteremia Cases due to Bacteroides Species

BACKGROUND: Differences in clinical characteristics and outcomes between community-acquired (CA) and healthcare-associated (HCA) Bacteroides bacteremia cases are not well known. METHODS: We evaluated all positive blood cultures between March 2012 and December 2016 in a Japanese 781-bed acute hospita...

Descripción completa

Detalles Bibliográficos
Autores principales: Ando, Naokatsu, Hayakawa, Kayoko, Katanami, Yuichi, Mezaki, Kazuhisa, Takaya, Saho, Yamamoto, Kei, Takeshita, Nozomi, Kutsuna, Satoshi, Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632262/
http://dx.doi.org/10.1093/ofid/ofx163.334
_version_ 1783269665115471872
author Ando, Naokatsu
Hayakawa, Kayoko
Katanami, Yuichi
Mezaki, Kazuhisa
Takaya, Saho
Yamamoto, Kei
Takeshita, Nozomi
Kutsuna, Satoshi
Ohmagari, Norio
author_facet Ando, Naokatsu
Hayakawa, Kayoko
Katanami, Yuichi
Mezaki, Kazuhisa
Takaya, Saho
Yamamoto, Kei
Takeshita, Nozomi
Kutsuna, Satoshi
Ohmagari, Norio
author_sort Ando, Naokatsu
collection PubMed
description BACKGROUND: Differences in clinical characteristics and outcomes between community-acquired (CA) and healthcare-associated (HCA) Bacteroides bacteremia cases are not well known. METHODS: We evaluated all positive blood cultures between March 2012 and December 2016 in a Japanese 781-bed acute hospital. Identification and susceptibility was performed based on CLSI criteria, and MALDI-TOF has been used since January 2015 in addition to conventional methods. RESULTS: Of 3611 bacteremia cases, 266 (7.4%) were due to obligately anaerobic bacteria, such as Clostridium species (n = 97 [36.5%]), Fusobacterium species (15 [7.5%]), and Bacteroides species (65 [24.4%]), of which 31 (47.7%) were HCA and 34 (52.3%) were CA. In 22 (33.8%) cases, > 2 blood cultures were positive. B. fragilis was most frequently isolated (n = 25 [38.5%]), then B. thetaiotaomicron (n = 9 [13.8%]), B. vulgatus (n = 5, [7.7%]), B. uniformis (n = 3 [4.6%]), B. distasonis (n = 2 [3.1%]), B. ureolyticus (n = 2 [3.1%]), B. capillosus (n = 1 [1.5%]), and B. ovatus (n = 1 [1.5%]). After introducing MALDI-TOF, the number of unidentified Bacteroides species fell from 12 (18.5%) to 5 (7.7%). Sensitivity to ampicillin/sulbactam, cefmetazole, and clindamycin was 85.2%, 92.6%, and 59.3%, respectively. Most bacteremia (51 [78.5%]) were of intra-abdominal origin. Baseline characteristics and immunocompromised status of HCA and CA Bacteroides bacteremia patients were similar, except for diabetes, which was more frequent in HCA cases (Table). There was significantly higher 7- and 30-day mortality in HCA than in CA cases (P = 0.03). CONCLUSION: The higher mortality in HCA Bacteroides bacteremia suggests the need for appropriate multidisciplinary management of these cases. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5632262
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56322622017-10-12 Comparison of Clinical Characteristics and Outcomes Between Community-Acquired and Healthcare-Associated Bacteremia Cases due to Bacteroides Species Ando, Naokatsu Hayakawa, Kayoko Katanami, Yuichi Mezaki, Kazuhisa Takaya, Saho Yamamoto, Kei Takeshita, Nozomi Kutsuna, Satoshi Ohmagari, Norio Open Forum Infect Dis Abstracts BACKGROUND: Differences in clinical characteristics and outcomes between community-acquired (CA) and healthcare-associated (HCA) Bacteroides bacteremia cases are not well known. METHODS: We evaluated all positive blood cultures between March 2012 and December 2016 in a Japanese 781-bed acute hospital. Identification and susceptibility was performed based on CLSI criteria, and MALDI-TOF has been used since January 2015 in addition to conventional methods. RESULTS: Of 3611 bacteremia cases, 266 (7.4%) were due to obligately anaerobic bacteria, such as Clostridium species (n = 97 [36.5%]), Fusobacterium species (15 [7.5%]), and Bacteroides species (65 [24.4%]), of which 31 (47.7%) were HCA and 34 (52.3%) were CA. In 22 (33.8%) cases, > 2 blood cultures were positive. B. fragilis was most frequently isolated (n = 25 [38.5%]), then B. thetaiotaomicron (n = 9 [13.8%]), B. vulgatus (n = 5, [7.7%]), B. uniformis (n = 3 [4.6%]), B. distasonis (n = 2 [3.1%]), B. ureolyticus (n = 2 [3.1%]), B. capillosus (n = 1 [1.5%]), and B. ovatus (n = 1 [1.5%]). After introducing MALDI-TOF, the number of unidentified Bacteroides species fell from 12 (18.5%) to 5 (7.7%). Sensitivity to ampicillin/sulbactam, cefmetazole, and clindamycin was 85.2%, 92.6%, and 59.3%, respectively. Most bacteremia (51 [78.5%]) were of intra-abdominal origin. Baseline characteristics and immunocompromised status of HCA and CA Bacteroides bacteremia patients were similar, except for diabetes, which was more frequent in HCA cases (Table). There was significantly higher 7- and 30-day mortality in HCA than in CA cases (P = 0.03). CONCLUSION: The higher mortality in HCA Bacteroides bacteremia suggests the need for appropriate multidisciplinary management of these cases. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5632262/ http://dx.doi.org/10.1093/ofid/ofx163.334 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Ando, Naokatsu
Hayakawa, Kayoko
Katanami, Yuichi
Mezaki, Kazuhisa
Takaya, Saho
Yamamoto, Kei
Takeshita, Nozomi
Kutsuna, Satoshi
Ohmagari, Norio
Comparison of Clinical Characteristics and Outcomes Between Community-Acquired and Healthcare-Associated Bacteremia Cases due to Bacteroides Species
title Comparison of Clinical Characteristics and Outcomes Between Community-Acquired and Healthcare-Associated Bacteremia Cases due to Bacteroides Species
title_full Comparison of Clinical Characteristics and Outcomes Between Community-Acquired and Healthcare-Associated Bacteremia Cases due to Bacteroides Species
title_fullStr Comparison of Clinical Characteristics and Outcomes Between Community-Acquired and Healthcare-Associated Bacteremia Cases due to Bacteroides Species
title_full_unstemmed Comparison of Clinical Characteristics and Outcomes Between Community-Acquired and Healthcare-Associated Bacteremia Cases due to Bacteroides Species
title_short Comparison of Clinical Characteristics and Outcomes Between Community-Acquired and Healthcare-Associated Bacteremia Cases due to Bacteroides Species
title_sort comparison of clinical characteristics and outcomes between community-acquired and healthcare-associated bacteremia cases due to bacteroides species
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632262/
http://dx.doi.org/10.1093/ofid/ofx163.334
work_keys_str_mv AT andonaokatsu comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies
AT hayakawakayoko comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies
AT katanamiyuichi comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies
AT mezakikazuhisa comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies
AT takayasaho comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies
AT yamamotokei comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies
AT takeshitanozomi comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies
AT kutsunasatoshi comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies
AT ohmagarinorio comparisonofclinicalcharacteristicsandoutcomesbetweencommunityacquiredandhealthcareassociatedbacteremiacasesduetobacteroidesspecies